This article is more than 5 years old. Information may no longer be current.
More than 10% of patients receiving EVAR readmitted within 30 days
Approximately 1 in 10 patients who had an endovascular aneurysm intervention between 2010 and 2014 was readmitted within 30 days, often due to cardiac complications or infections, researchers reported.
However, the 30-day readmission rate declined between 2010 and 2014.
The researchers analyzed 138,014 patients (81% men; 52% younger than 75 years) from the U.S. Healthcare Utilization Project’s Nationwide Readmission Database who had endovascular aneurysm repair or other endovascular aneurysm intervention between 2010 and 2014.
Varunsiri Atti, MD, from the department of medicine at Michigan State University, and colleagues found that 10.24% of the cohort was readmitted within 30 days, and the median time to readmission was 11 days.
The most common causes of readmission were cardiac causes (16.34%), infections (15.4%) and vascular complications (12.86%), according to the researchers.
“Cardiac conditions, infections and vascular complications were the most common causes for readmission, highlighting the importance of procedural optimization and appropriate periprocedural care,” Atti and colleagues wrote.
Independent predictors of 30-day readmission included older age (aged 75-85 years, OR = 1.19; P = .001; older than 85 years, OR = 1.19; P = .001), female sex (OR = 1.31; P < .0001),
HF (OR = 1.31; P < .0001), atrial fibrillation (OR = 1.25; P < .0001), peripheral vascular disease (OR = 1.16; ; P < .0001), lung disease (OR = 1.17; P < .0001), chronic kidney disease (OR = 1.21; P < .0001), major bleeding during index admission (OR = 1.17; P = .01) and vascular complications during index admission (OR = 1.16; P = .004).
According to the researchers, 30-day readmission rates declined from 11.3% in 2010 to 9.6% in 2014 (P for trend < .0001; OR for 2014 vs. 2010 = 0.8; 95% CI, 0.72-0.87).
“Our study adds to the current literature by including national-level estimates over a 5-year period, making it the largest report to date,” Atti and colleagues wrote. “The readmission rate in our study is comparable with the rates reported in the existing literature.” – by Erik Swain
Disclosures: Atti reports no relevant financial disclosures. Please see the study for all other authors’ relevant financial disclosures.